Veterinary Medicines

CORTEXILINE

Not authorised
  • NEOMYCIN SULFATE
  • Methylprednisolone
  • Benzylpenicillin procaine monohydrate
Download as PDF

Product identification

Medicine name:
CORTEXILINE
Active substance:
  • NEOMYCIN SULFATE
  • Methylprednisolone
  • Benzylpenicillin procaine monohydrate
Target species:
  • Cattle
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    169.01
    milligram(s)
    /
    1.00
    millilitre(s)
  • Methylprednisolone
    4.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Benzylpenicillin procaine monohydrate
    200.57
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        60
        day
      • Milk
        9
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RV01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France SCS
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/9861360 7/1985
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 24/03/2022
Download